Literature DB >> 27415419

The esophageal microbiota in health and disease.

Vincenzo Di Pilato1, Giancarlo Freschi2,3, Maria Novella Ringressi2,3, Lucia Pallecchi4, Gian Maria Rossolini4,5,6,7, Paolo Bechi2,3.   

Abstract

The esophageal mucosa is among the sites colonized by human microbiota, the complex microbial ecosystem that colonizes various body surfaces and is increasingly recognized to play roles in several physiological and pathological processes. Our understanding of the composition of the esophageal microbiota in health and disease is challenged by the need for invasive sampling procedures and by the dynamic nature of the esophageal environment and remains limited in comparison with the information available for other body sites. Members of the genus Streptococcus appear to be the major components of the microbiota of the healthy esophagus, although the presence of several other taxa has also been reported. Dysbiosis, consisting of enrichment in some Gram-negative taxa (including Veillonella, Prevotella, Haemophilus, Neisseria, Campylobacter, and Fusobacterium), has been reported in association with gastroesophageal reflux disease and is hypothesized to contribute to the evolution of this condition toward Barrett's esophagus (which is the most common esophageal precancerous lesion) and, eventually, adenocarcinoma. Some Campylobacter species (mostly C. concisus) are also putatively involved in the progression of disease toward adenocarcinoma. However, variable findings have recently been reported in additional studies. Causative relationships between dysbiosis or specific bacterial species and esophageal diseases remain controversial and warrant further investigations.
© 2016 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals, Inc. on behalf of New York Academy of Sciences.

Entities:  

Keywords:  Barrett's esophagus; esophageal adenocarcinoma; esophageal diseases; esophageal squamous cell carcinoma; esophagitis; microbiota

Mesh:

Substances:

Year:  2016        PMID: 27415419     DOI: 10.1111/nyas.13127

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

Review 1.  Esophageal perforation: a research review of the anti-infective treatment.

Authors:  Jennifer Gregory; Jason Hecht
Journal:  Int J Clin Pharm       Date:  2018-06-28

Review 2.  The Esophageal Microbiome in Health and Disease.

Authors:  Brooke Corning; Andrew P Copland; Jeanetta W Frye
Journal:  Curr Gastroenterol Rep       Date:  2018-08-01

3.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

4.  The Salivary Microbiome and Oral Cancer Risk: a Pilot Study in Fanconi Anemia.

Authors:  C P Furquim; G M S Soares; L L Ribeiro; M A Azcarate-Peril; N Butz; J Roach; K Moss; C Bonfim; C C Torres-Pereira; F R F Teles
Journal:  J Dent Res       Date:  2016-11-13       Impact factor: 6.116

Review 5.  The gut microbiota and gastrointestinal surgery.

Authors:  Kristina Guyton; John C Alverdy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-12       Impact factor: 46.802

6.  Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.

Authors:  Shegan Gao; Yiwen Liu; Xiaoxian Duan; Ke Liu; Muddasir Mohammed; Zhen Gu; Junling Ren; Lan Yakoumatos; Xiang Yuan; Lanhai Lu; Shuang Liang; Jiong Li; David A Scott; Richard J Lamont; Fuyou Zhou; Huizhi Wang
Journal:  Br J Cancer       Date:  2021-05-12       Impact factor: 7.640

7.  Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study.

Authors:  Fangfang Liu; Mengfei Liu; Ying Liu; Chuanhai Guo; Yunlai Zhou; Fenglei Li; Ruiping Xu; Zhen Liu; Qiuju Deng; Xiang Li; Chaoting Zhang; Yaqi Pan; Tao Ning; Xiao Dong; Zhe Hu; Huanyu Bao; Hong Cai; Isabel Dos Santos Silva; Zhonghu He; Yang Ke
Journal:  Chin J Cancer Res       Date:  2020-12-31       Impact factor: 5.087

8.  Cross-talk among metabolic parameters, esophageal microbiota, and host gene expression following chronic exposure to an obesogenic diet.

Authors:  Nadeem O Kaakoush; Virginie Lecomte; Christopher A Maloney; Margaret J Morris
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

Review 9.  Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications.

Authors:  Yoshifumi Baba; Masaaki Iwatsuki; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2017-06-07

Review 10.  Gut microbiome: a new player in gastrointestinal disease.

Authors:  Gregor Gorkiewicz; Alexander Moschen
Journal:  Virchows Arch       Date:  2017-12-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.